Last edition
News about "chronic diseases"
Syneron Bio Signs Strategic Partnership with AstraZeneca
Under this collaboration, AstraZeneca will gain access to Syneron Bio's innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases.
Chronic Diseases | 24/03/2025 | By Aishwarya | 332
Lilly Completes Acquisition of Morphic
Morphic is a biopharmaceutical company developing oral integrin therapies for the treatment of serious chronic diseases, including a selective oral small molecule inhibitor of α4β7 integrin (known as MORF-057) for inflammatory bowel disease (IBD).
Chronic Diseases | 17/08/2024 | By Aishwarya | 189
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy